Transitory decrease in platelet monoamine-oxidase activity during migraine attacks.
A highly significant decrease in platelet monoamine-oxidase activity has been observed in migrainous subjects during a migraine attack compared with activity outside an attack. The effect did not derive from drugs commonly used in migraine therapy.
D000293:Adolescent; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000201:enzymology*; D001798:Blood Proteins / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D003000:Clonidine / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000097:blood / Q000201:enzymology* / Q000209:etiology; D008995:Monoamine Oxidase / Q000097:blood / Q000172:deficiency; D014439:Tyramine / Q000097:blood
D001798:Blood Proteins; D008995:Monoamine Oxidase; D003000:Clonidine; D004878:Ergotamine; D003975:Diazepam; D001241:Aspirin; D014439:Tyramine